3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide

We are 3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide CAS:1228779-96-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)benzenesulfonamide
CAS.NO:  1228779-96-1
Synonyms:3-Nitro-4-[[(tetrahydropyran-4-yl)methyl]amino]benzenesulfonamide
Benzenesulfonamide, 3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]-

Molecular Formula: C12H17N3O5S
Molecular Weight:315.34500

Physical and Chemical Properties:
Density: 1.4±0.1 g/cm3
Boiling point: 542.0±60.0 °C at 760 mmHg
Melting point: /
Flash point: 281.6±32.9 °C
Refractive index: 1.600

Specification:
Appearance:White  powder
Purity:≥99.0%

Packing:
 25kg 1 cardboard drum or according to customer specified requirements
Storage:Shade light and keep tightly closed.
Application: Intermediates of ABT-199 CAS:1257044-40-8.

Related News: Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs.2-cloro-N- (2-cloro-4-metilpiridin-3-il) nicotinamida CAS:133627-46-0 Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs.2-bromo-5-fluoroanilina CAS:1003-99-2 Retrogenix holds two Queen’s Awards for Enterprise, the UK’s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA.55314-16-4 At the same time, experts said that API companies need to increase investment in environmental protection, carry out industrial upgrades, improve processes, improve pollution treatment capabilities, and then achieve sustainable development in the future, and seize structural opportunities.In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .